GlassScriptPhysician profile
Opal N Lowe
NPI 1518678671
$566.54
in general payments reported to CMS, 2019-2025
8 companies · $60.84 in 2025
The $60.84 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $189 · 2024: $317 · 2025: $60.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $126.65 | 2023 | Impella |
| Viiv Healthcare Company | $76.72 | 2024 | Apretude |
| Exact Sciences Corporation | $67.70 | 2024 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $62.47 | 2023 | Quviviq |
| Eisai INC. | $61.12 | 2024 | |
| Lilly USA, LLC | $60.84 | 2025 | Zepbound |
| Insmed, INC. | $57.16 | 2024 | Arikayce |
| Neurocrine Biosciences, INC. | $53.88 | 2024 | Ingrezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Opal Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.